Trading Signals: NVTA Stock Price Prediction and Forecast (Thu. Feb. 12, 2015 - Fri. May. 13, 2022)(Invitae Corp)
| NVTA latest price $5.6800 (5.77%) ($5.3050 - $5.7200) on Mon. Apr. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.32% (three month average) | RSI | 14 | Latest Price | $5.6800(5.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | NVTA declines -1.4% a day on average for past five trading days. | Weekly Trend | NVTA declines -14.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support NVTA advance at 0% a week (0% probability) BOTZ(99%) XAR(98%) XBI(98%) EWJ(97%) SKYY(97%) | Factors Impacting NVTA price | NVTA will decline at least -3.16% in a week (0% probabilities). TIP(-34%) SHY(-32%) BNDX(-19%) UUP(-14%) BND(-13%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.16% (StdDev 6.32%) | Hourly BBV | 0.8 () | Intraday Trend | 7.2% | | | |
|
1 - 5 Day Possible Target | $-20.98(-469.37%) | Resistance Level | $7.09 | 5 Day Moving Average | $5.71(-0.53%) | 10 Day Moving Average | $6.17(-7.94%) | 20 Day Moving Average | $7.09(-19.89%) | To recent high | -51.2% | To recent low | 5.8% | Market Cap | $973m | | | | Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA. |